Famotidine powder for suspension is a versatile treatment option for various acid-related gastrointestinal disorders, offering effective relief and promoting healing.
Oxcarbazepine oral suspension is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures.
Erythromycin is used to prevent and treat infections. The product will be launched on February 15th 2025.
Erythromycin is used to prevent and treat infections. The product will be launched on February 15th 2025.
Erythromycin is used to prevent and treat infections. The product will be launched on February 15th 2025.
Need a Solution?